Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease

Aim of the study was to explore the correlation between the progression of carotid atherosclerosis and the evolution of cognitive impairment in 66 patients with Alzheimer's disease (AD). They underwent cognitive status evaluation and ultrasonography (US) to investigate carotid arteries intima-media thickness (IMT) and plaque index (PI). After a 12-month follow-up period, neuropsychological and US examinations were repeated to assess the progression of carotid atherosclerosis and of cognitive decline [in terms of changes in Mini Mental State Examination (MMSE) scores]. MMSE score changes were related to baseline IMT (p=0.018), changes in IMT (p<0.001) and PI (p=0.006), and "antihypertensive drug intake" (p<0.001). While the first three variables correlated with increased cognitive impairment, the last one was associated with a reduced extent of MMSE score decline. Results show a link between progression of carotid wall changes and of cognitive decline, and suggest a possible protective role of antihypertensive therapy. Given the potential clinical implications, our preliminary findings could stimulate further investigations into the role of vascular impairment in patients with AD.

[1]  D. Bennett,et al.  Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. , 2001, Archives of neurology.

[2]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[3]  Lenore J Launer,et al.  Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension , 2006, Stroke.

[4]  P. Passmore,et al.  The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. , 2006, The Cochrane database of systematic reviews.

[5]  J. Cerhan,et al.  Correlates of Cognitive Function in Middle-Aged Adults , 1998, Gerontology.

[6]  P Ducimetière,et al.  Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Zandi,et al.  Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. , 2006, Archives of neurology.

[8]  P. Scheltens,et al.  A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.

[9]  K. Matthews,et al.  Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. , 1998, Stroke.

[10]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[11]  L. Prockop,et al.  Color-Coded Duplex Ultrasonography of the Cerebral Vessels , 1999 .

[12]  L. V. van Doornen,et al.  Does carotid endarterectomy improve cognitive functioning? , 2005, Journal of vascular surgery.

[13]  Alzheimer's disease and angiogenesis , 2003 .

[14]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[15]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[16]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[17]  A. Hofman,et al.  Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.

[18]  E. Reiman,et al.  Vascular risk factors, incidence of MCI, and rates of progression to dementia , 2004, Neurology.

[19]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[20]  H. Vinters,et al.  The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease , 2002, Brain pathology.

[21]  L S Honig,et al.  Aggregation of vascular risk factors and risk of incident Alzheimer disease , 2005, Neurology.

[22]  Fabrizio Vernieri,et al.  Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease , 2006, Stroke.

[23]  J. Staessen,et al.  Carotid Intima-Media Thickness and Antihypertensive Treatment: A Meta-Analysis of Randomized Controlled Trials , 2006, Stroke.

[24]  J. Bray,et al.  Quantification of Atheromatous Stenosis in the Extracranial Internal Carotid Artery , 1995 .

[25]  G Bernardi,et al.  Carotid Artery Intima-Media Thickness and Lacunar Versus Nonlacunar Infarcts , 2002, Stroke.

[26]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[27]  B. Lebowitz,et al.  Norms for the Mini-Mental State Examination in a healthy population , 1999, Neurology.

[28]  B. Reed,et al.  Application of item response theory for development of a global functioning measure of dementia with linear measurement properties. , 2000, Statistics in medicine.

[29]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[30]  M Williams,et al.  Angiographic and Duplex Grading of Internal Carotid Stenosis: Can We Overcome the Confusion? , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

[31]  B. Winblad,et al.  Statin therapy in Alzheimer's disease , 2005, The Lancet Neurology.

[32]  J. C. Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002 .

[33]  R. Mayeux,et al.  Atherosclerosis and AD , 2005, Neurology.

[34]  L. Fried,et al.  Cognitive Impairment and Decline Are Associated with Carotid Artery Disease in Patients without Clinically Evident Cerebrovascular Disease , 2004, Annals of Internal Medicine.

[35]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[36]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[37]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[38]  C. Iadecola,et al.  Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia , 2003, Stroke.

[39]  Thomas G. Beach,et al.  Atherosclerosis of Cerebral Arteries in Alzheimer Disease , 2004, Stroke.

[40]  R. Rao.  The Role of Carotid Stenosis in Vascular Cognitive Impairment , 2001, European Neurology.